Brian Kotzin

Dr. Brian L.
Kotzin, MD, is an Independent Director at Kyverna Therapeutics, Inc., an Independent Director at Biora Therapeutics, Inc., an Independent Director at Rigel Pharmaceuticals, Inc., a Member at American Society of Clinical Investigation and a Member at Association of American Physicians.
He is on the Board of Directors at argenx SE, Kyverna Therapeutics, Inc., Biora Therapeutics, Inc., Rigel Pharmaceuticals, Inc., Benaroya Research Institute at Virginia Mason and Genascence Corp.
Dr. Kotzin was previously employed as a Chief Medical Officer & Senior Vice President by Nektar Therapeutics, a VP-Global Clinical Development & Head-Inflammation by Amgen, Inc., a Director & Head-Clinical Immunology by Autoimmunity Center of Excellence, a Chairman-Immunological Sciences Study Section by National Institues of Health, a Professor by National Jewish Health, Inc., a Professor by University of Colorado Health Sciences Center, and a Chief-Rheumatology Section by Veterans Administration Medical Center.
He also served on the board at Vera Therapeutics, Inc., American College of Rheumatology and Federation of Clinical Immunology Societies.
He received his undergraduate degree from the University of Southern California and a doctorate degree from Stanford University School of Medicine.